Sarcoma  >>  elesclomol (STA-4783)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
elesclomol (STA-4783) / Madrigal Pharma
NCT00087997: A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas

Completed
2
80
US, Canada
STA-4783
Synta Pharmaceuticals Corp.
Soft Tissue Sarcoma
 
10/05

Download Options